MedPath

An Explorative Randomized Controlled Investigation Evaluating Newly Developed Ostomy Products

Not Applicable
Completed
Conditions
Ileostomy
Interventions
Device: Test A
Device: Test B
Device: Baseline
Registration Number
NCT02351817
Lead Sponsor
Coloplast A/S
Brief Summary

The primary objective of the investigation is to explore the acceptance of a newly developed adhesive.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Have given written informed consent and letter of authority
  • Be at least 18 years of age and have full legal capacity
  • Be able to handle the products her/himself
  • Have an ileostomy with a diameter between 10 and 30 mm
  • Willing to follow the product change schedule (one change per day)
  • Have had their ostomy for at least three months
  • Willing to use 1 piece open ostomy products during the test period
  • Must be able to use a custom cut product
  • Have intact skin
  • Negative result of a pregnancy test for women of childbearing age
Exclusion Criteria
  • Currently receiving or have within the past 2 months received radio- and/or chemotherapy
  • Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/ injection) treatment
  • Is pregnant or breastfeeding.
  • Is participating in other interventional clinical investigations or have previously participated in this investigation
  • Have a loop ileostomy
  • Known hypersensitivity towards any of the test products

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Baseline - Test A - Test BBaselineThree period investigation. First each subject tests baseline product, then Test A and finally Test B. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Baseline - Test A - Test BTest BThree period investigation. First each subject tests baseline product, then Test A and finally Test B. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Baseline - Test A - Test BTest AThree period investigation. First each subject tests baseline product, then Test A and finally Test B. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Baseline - Test B - Test ABaselineFirst each subject tests baseline product, then Test B and finally Test A. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Baseline - Test B - Test ATest AFirst each subject tests baseline product, then Test B and finally Test A. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Baseline - Test B - Test ATest BFirst each subject tests baseline product, then Test B and finally Test A. Baseline product: the subject's usual product Test A: A newly developed 1-piece, open ostomy appliance for collecting feces Test B: A newly developed 1-piece, open ostomy appliance for collecting feces
Primary Outcome Measures
NameTimeMethod
Product Acceptance7 days per test period

Product acceptance was measurement qualitatively by interviews exploring the factors and mechanisms affecting the acceptance. The interview questions were formulated in such a way that was not possible to quantify the number of subjects accepting the test products.

There were problems with test product performance and handling and therefore the acceptance of the products was not high. Product preference was secondary endpoint, where the subjects were asked whether they preffered their own product over the test products. This endpoint is the best measure we have for mimiking product acceptance. However, we are aware subjects could accept a product without preferring it over own product and the preferrence result might therefore not be accurate.

The result presented below shows how many subjects preferred Test A/Test B over own product

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Coloplast A/S

🇩🇰

Humlebaek, Denmark

Coloplast A/S
🇩🇰Humlebaek, Denmark
© Copyright 2025. All Rights Reserved by MedPath